Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
78,822,261
-
Total 13F shares
-
38,479,556
-
Share change
-
+18,962,287
-
Total reported value
-
$158,542,263
-
Put/Call ratio
-
16%
-
Price per share
-
$4.12
-
Number of holders
-
75
-
Value change
-
+$81,995,664
-
Number of buys
-
58
-
Number of sells
-
5
Institutional Holders of Eledon Pharmaceuticals, Inc. - Common Stock (ELDN) as of Q4 2024
As of 31 Dec 2024,
Eledon Pharmaceuticals, Inc. - Common Stock (ELDN) was held by
75 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
38,479,556 shares.
The largest 10 holders included
BVF INC/IL, RA CAPITAL MANAGEMENT, L.P., VANGUARD GROUP INC, SPHERA FUNDS MANAGEMENT LTD., First Light Asset Management, LLC, Blue Owl Capital Holdings LP, Woodline Partners LP, Schonfeld Strategic Advisors LLC, Ensign Peak Advisors, Inc, and Frazier Life Sciences Management, L.P..
This page lists
75
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.